borderline non-significantp = 0.052
Effect of Treatment on Glucose Metabolism Markers Fasting blood glucose (FBG): The baseline FBG levels appeared to be slightly higher for the active treatment group (7 mmol/L) than the placebo group (6 mmol/L) but this was borderline non-significant ( p = 0.052) ( Table 2 ).